Canon has resolved and executed an agreement for a simple absorption-type merger involving its 100% subsidiary CETD. The scheduled effective date is January 1, 2027. The surviving company will be Canon Inc., and the dissolved company will be Canon Electron Tube Devices Co., Ltd. The integration aims to consolidate the Medical Business Unit’s component operations and maximize synergies. Financial impact is expected to be minimal.<\/p>\n","protected":false},"comment_status":"open","ping_status":"closed","template":"","meta":{"Ticker":"","DATE":"","longName":"","company_name_ja":"","fullTimeEmployees":0,"address":"","phone":"","website":"","industry":"","sector":"","regularMarketPrice":0,"financialCurrency":"","marketCap":0,"fiftyTwoWeekLow":0,"fiftyTwoWeekHigh":0,"epsTrailingTwelveMonths":0,"epsForward":0,"bookValue":0,"totalRevenue":0,"OperatingIncome":0,"operatingMargins":0,"NetIncome":0,"profitMargins":0,"ebitda":0,"trailingPE":0,"forwardPE":0,"priceToBook":0,"returnOnEquity":0,"recommendationMean":0,"recommendationKey":"","targetMeanPrice":0,"numberOfAnalystOpinions":0,"analyst_earnings_data":"","dividendRate":0,"dividendYield":0,"payoutRatio":0,"totalEsg":0,"environmentScore":0,"socialScore":0,"governanceScore":0,"title":"","providerPublishTime":"","link":"","longBusinessSummary":"","longBusinessSummary_ja":"","quarterly_revenue":0,"quarterly_net_income":0,"quarterly_operating_profit":0,"enterprise_value":0,"price_fetched_at":"","company_officer_1_name":"","company_officer_1_title":"","company_officer_2_name":"","company_officer_2_title":"","company_officer_3_name":"","company_officer_3_title":"","company_officer_4_name":"","company_officer_4_title":"","company_officer_5_name":"","company_officer_5_title":"","company_officers_update_time":"","get_dividend_history_year1":0,"get_dividend_history_year2":0,"get_dividend_history_year3":0,"get_dividend_history_year4":0,"get_dividend_history_year5":0,"get_dividend_history_year6":0,"get_dividend_history_year7":0,"get_dividend_history_year8":0,"get_dividend_history_year9":0,"get_dividend_history_year10":0,"site-sidebar-layout":"default","site-content-layout":"","ast-site-content-layout":"","site-content-style":"default","site-sidebar-style":"default","ast-global-header-display":"","ast-banner-title-visibility":"","ast-main-header-display":"","ast-hfb-above-header-display":"","ast-hfb-below-header-display":"","ast-hfb-mobile-header-display":"","site-post-title":"","ast-breadcrumbs-content":"","ast-featured-img":"","footer-sml-layout":"","theme-transparent-header-meta":"","adv-header-id-meta":"","stick-header-meta":"","header-above-stick-meta":"","header-main-stick-meta":"","header-below-stick-meta":"","astra-migrate-meta-layouts":"default","ast-page-background-enabled":"default","ast-page-background-meta":{"desktop":{"background-color":"var(--ast-global-color-5)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"ast-content-background-meta":{"desktop":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"tablet":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""},"mobile":{"background-color":"var(--ast-global-color-4)","background-image":"","background-repeat":"repeat","background-position":"center center","background-size":"auto","background-attachment":"scroll","background-type":"","background-media":"","overlay-type":"","overlay-color":"","overlay-opacity":"","overlay-gradient":""}},"jir_stock_code":"7751","jir_company_name":"Canon Inc.","jir_importance":"\u2605\u2605\u2605\u2605\u2606","jir_publication_date":"2026-10-27","jir_source_link":"https:\/\/japanir.jp\/wp-content\/uploads\/2026\/10\/7751-20261027-02.pdf","jir_short_summary":"Canon has resolved and executed an agreement for a simple absorption-type merger involving its 100% subsidiary CETD. The scheduled effective date is January 1, 2027. The surviving company will be Canon Inc., and the dissolved company will be Canon Electron Tube Devices Co., Ltd. The integration aims to consolidate the Medical Business Unit's component operations and maximize synergies. Financial impact is expected to be minimal.","jir_summary":"### Overview of the Absorption-Type Merger\nAt today's Board meeting, Canon Inc. resolved to carry out a simple absorption-type merger with Canon Inc. as the surviving company and Canon Electron Tube Devices Co., Ltd. as the dissolved company, and executed the agreement with an effective date of January 1, 2027. No allotment will be made, and it is noted that CETD has not issued any stock acquisition rights.\n\n### Outlook and Impact\nThis absorption-type merger involves the Company and its wholly owned subsidiary, and the impact on consolidated results is expected to be minor. By integrating the Medical Business Unit's component operations, the aim is to unify the foundations for development, production, sales and administration to enhance synergies and cost competitiveness, accelerating profitability and growth.","jir_financial_highlights":"Net Assets: Unknown (Unknown)","jir_category":"","jir_hashtags":"#NoShareBuyback, #NoExecutivePersonnelChanges","jir_key_figures":"Scheduled effective date of this absorption-type merger: 2027-01-01 (scheduled)\nMethod of this absorption-type merger: Canon Inc. as surviving company, CETD as dissolved company\nCapital structure \/ Major shareholder: CETD is 100% owned (Canon Inc. holds 100%)","jir_meta_title":"Canon Inc. - Notice of Execution of Absorption-Type Merger Agreement | Effective Date Scheduled January 1, 2027","jir_meta_description":"Canon Inc. has resolved and executed a simple absorption-type merger with its subsidiary Canon Electron Tube Devices to integrate the Medical Business Unit's component operations and strengthen competitiveness; the financial impact is expected to be minimal.","jir_og_title":"Canon Inc. - Notice of Execution of Absorption-Type Merger Agreement | Scheduled January 1, 2027","jir_og_description":"Canon Inc. has resolved and executed a simple absorption-type merger with CETD to integrate and strengthen the medical business; the effective date is scheduled for January 1, 2027.","jir_og_image_url":"\/assets\/og\/company-general_ir.jpg","jir_chart_data_collection":"[]","ir_related_company":6858,"ir_release_date":"","ir_type":"","ir_is_new":false,"ir_document_url":"","jir_ir_type":"corporate_restructuring","footnotes":""},"sector":[],"importance":[],"class_list":["post-134794","ir_release","type-ir_release","status-publish","hentry"],"yoast_head":"\n